Funded Tech Companies

NewLimit

Headquartered in San Francisco, NewLimit has funding from Eli Lilly and Company, Valor Equity Partners and Thrive Capital.

Company Overview

Contact Information

Company Background Information

Overview

NewLimit is a biotechnology company working to radically extend human healthspan. We're developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional genomics, pooled perturbation screening, and machine learning models to unravel the biology of epigenetic aging and disease using experiments of unprecedented scale.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

6/3/2026

Financing History

Management Team

Title

Name

Email & Social

Co-Founder

Brian Armstrong

        

Co-Founder

Greg Johnson

        

Co-Founder

Jacob Kimmel

        

President

Michael Polansky

        

Company Investors

• Eli Lilly and Company
• Valor Equity Partners
• Thrive Capital
• Founders Fund
• Kleiner Perkins
• Greenoaks Capital Partners
• Quiet Capital
• Human Capital
• Abstract Ventures
• Private Investors (Daniel Gross)
• Private Investors (Nat Friedman)
• Dimension
• Khosla Ventures
• Private Investors (Brian Armstrong)
• Private Investors (Elad Gil)
• Private Investors (Fred Ehrsam)
• Private Investors (Garry Tan)
• Private Investors (Joe Lonsdale)
• Private Investors (John Collison)
• Private Investors (Joshua Kushner)
• Private Investors (Patrick Collison)
• Kleiner Perkins Caufield & Byers

Browse more funded tech companies:

Newlight Technologies | NewLink Genetics

Share this article

About Our Venture Capital Database

Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary